KR100830282B1 - 모락셀라 카탈리스로부터의 basb027 단백질 및유전자, 항원, 항체, 및 이들의 용도 - Google Patents

모락셀라 카탈리스로부터의 basb027 단백질 및유전자, 항원, 항체, 및 이들의 용도 Download PDF

Info

Publication number
KR100830282B1
KR100830282B1 KR1020007013705A KR20007013705A KR100830282B1 KR 100830282 B1 KR100830282 B1 KR 100830282B1 KR 1020007013705 A KR1020007013705 A KR 1020007013705A KR 20007013705 A KR20007013705 A KR 20007013705A KR 100830282 B1 KR100830282 B1 KR 100830282B1
Authority
KR
South Korea
Prior art keywords
polypeptide
seq
polynucleotide
host cell
basb027
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007013705A
Other languages
English (en)
Korean (ko)
Other versions
KR20010052552A (ko
Inventor
까를로따 비날스 와이 데 바솔즈
Original Assignee
글락소스미스클라인 바이오로지칼즈 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811945.6A external-priority patent/GB9811945D0/en
Priority claimed from GBGB9905304.3A external-priority patent/GB9905304D0/en
Application filed by 글락소스미스클라인 바이오로지칼즈 에스.에이. filed Critical 글락소스미스클라인 바이오로지칼즈 에스.에이.
Publication of KR20010052552A publication Critical patent/KR20010052552A/ko
Application granted granted Critical
Publication of KR100830282B1 publication Critical patent/KR100830282B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020007013705A 1998-06-03 1999-05-31 모락셀라 카탈리스로부터의 basb027 단백질 및유전자, 항원, 항체, 및 이들의 용도 Expired - Fee Related KR100830282B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9811945.6A GB9811945D0 (en) 1998-06-03 1998-06-03 Novel compounds
GB9811945.6 1999-03-08
GB9905304.3 1999-03-08
GBGB9905304.3A GB9905304D0 (en) 1999-03-08 1999-03-08 Novel compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020067024958A Division KR100911277B1 (ko) 1998-06-03 1999-05-31 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도

Publications (2)

Publication Number Publication Date
KR20010052552A KR20010052552A (ko) 2001-06-25
KR100830282B1 true KR100830282B1 (ko) 2008-05-16

Family

ID=26313784

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020007013705A Expired - Fee Related KR100830282B1 (ko) 1998-06-03 1999-05-31 모락셀라 카탈리스로부터의 basb027 단백질 및유전자, 항원, 항체, 및 이들의 용도
KR1020077019114A Ceased KR20070089890A (ko) 1998-06-03 1999-05-31 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도
KR1020067024958A Expired - Fee Related KR100911277B1 (ko) 1998-06-03 1999-05-31 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020077019114A Ceased KR20070089890A (ko) 1998-06-03 1999-05-31 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도
KR1020067024958A Expired - Fee Related KR100911277B1 (ko) 1998-06-03 1999-05-31 모락셀라 카탈리스로부터의 basb027 단백질 및 유전자,항원, 항체, 및 이들의 용도

Country Status (22)

Country Link
US (3) US6803043B1 (cg-RX-API-DMAC7.html)
EP (1) EP1082435B1 (cg-RX-API-DMAC7.html)
JP (1) JP4503177B2 (cg-RX-API-DMAC7.html)
KR (3) KR100830282B1 (cg-RX-API-DMAC7.html)
CN (1) CN1311820B (cg-RX-API-DMAC7.html)
AT (1) ATE341628T1 (cg-RX-API-DMAC7.html)
AU (1) AU738896B2 (cg-RX-API-DMAC7.html)
BR (1) BR9911609A (cg-RX-API-DMAC7.html)
CA (1) CA2331196A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105820T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296086B6 (cg-RX-API-DMAC7.html)
DE (1) DE69933444T2 (cg-RX-API-DMAC7.html)
DK (1) DK1082435T3 (cg-RX-API-DMAC7.html)
ES (1) ES2274627T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0102235A3 (cg-RX-API-DMAC7.html)
IL (2) IL139951A0 (cg-RX-API-DMAC7.html)
NO (1) NO327201B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ508617A (cg-RX-API-DMAC7.html)
PL (1) PL198031B1 (cg-RX-API-DMAC7.html)
PT (1) PT1082435E (cg-RX-API-DMAC7.html)
TR (1) TR200003608T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999063093A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US20030157522A1 (en) * 2001-11-09 2003-08-21 Alain Boudreault Methods and reagents for peptide-BIR interaction screens
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
BE1006377A3 (fr) 1992-11-24 1994-08-09 Raffinerie Tirlemontoise Sa Procede de separation d'une composition polydispersee de saccharides, produits obtenus par ce procede et utilisation des produits obtenus dans des compositions alimentaires.
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics

Also Published As

Publication number Publication date
US20040265331A1 (en) 2004-12-30
US6803043B1 (en) 2004-10-12
CA2331196A1 (en) 1999-12-09
PL198031B1 (pl) 2008-05-30
NO20006112L (no) 2001-02-02
NO20006112D0 (no) 2000-12-01
ATE341628T1 (de) 2006-10-15
KR20070089890A (ko) 2007-09-03
AU4373299A (en) 1999-12-20
IL139951A (en) 2008-08-07
DE69933444T2 (de) 2007-03-29
IL139951A0 (en) 2002-02-10
AU738896B2 (en) 2001-09-27
PT1082435E (pt) 2007-01-31
WO1999063093A2 (en) 1999-12-09
BR9911609A (pt) 2001-02-06
WO1999063093A3 (en) 2000-03-02
TR200003608T2 (tr) 2001-04-20
HK1037209A1 (en) 2002-02-01
KR100911277B1 (ko) 2009-08-11
EP1082435A2 (en) 2001-03-14
NZ508617A (en) 2003-08-29
HUP0102235A1 (hu) 2001-10-28
EP1082435B1 (en) 2006-10-04
US7641910B2 (en) 2010-01-05
US20100143412A1 (en) 2010-06-10
ES2274627T3 (es) 2007-05-16
CY1105820T1 (el) 2011-02-02
CZ296086B6 (cs) 2006-01-11
KR20060129108A (ko) 2006-12-14
HUP0102235A3 (en) 2004-10-28
CN1311820A (zh) 2001-09-05
CZ20004510A3 (cs) 2001-07-11
KR20010052552A (ko) 2001-06-25
PL345193A1 (en) 2001-12-03
DE69933444D1 (de) 2006-11-16
NO327201B1 (no) 2009-05-11
CN1311820B (zh) 2011-11-16
JP4503177B2 (ja) 2010-07-14
JP2002517199A (ja) 2002-06-18
DK1082435T3 (da) 2007-02-05

Similar Documents

Publication Publication Date Title
US20100143412A1 (en) Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
US20030161835A1 (en) Polypeptides from moraxella (branhamella) catarrhalis
US7592158B2 (en) BASB019 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses
KR100610448B1 (ko) 모락셀라 카탈리스로부터의 화합물
US7432366B2 (en) Moraxella catarrhalis BASB034 polypeptides and used thereof
US6706269B1 (en) Moraxella catarrhalis PILQ proteins
US6706271B1 (en) Cloning of BASB023 antigen from Moraxella catarrhalis
HK1037209B (en) Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
ZA200007108B (en) BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses.

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

A107 Divisional application of patent
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20110428

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20120510

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20120510